0866 022 097
institute@mescells.com
Efficacy of Autologous Bone Marrow-Derived Mesenchymal Stem Cells and Mononuclear Cells Transplantation in Type 2 Diabetes Mellitus: A Randomized Placebo-Controlled Comparative Study
27/08/2023
Stem Cells and Development
© Mary Ann Liebert, Inc.
DOI: 10.1089/scd.2016.0275
© Mary Ann Liebert, Inc.
DOI: 10.1089/scd.2016.0275
Efficacy of Autologous Bone Marrow-Derived Mesenchymal Stem Cells and Mononuclear Cells Transplantation in Type 2 Diabetes Mellitus: A Randomized Placebo-Controlled Comparative Study
Short Running Title- Stem cells transplantation in T2DM
Shobhit Bhansali, Pinaki Dutta, Vinod Kumar, Mukesh Kumar Yadav, Ashish Jain, Sunder Mudaliar, Shipra Bhansali, Ratti Ram Sharma, Vivekanand Jha, Neelam Marwaha, Niranjan Khandelwal, Anand Srinivasan, Naresh Sachdeva, Meredith Hawkins, and Anil Bhansali,
Hotline
Zalo
Messenger
Fanpage